These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 3141322

  • 1. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE, Fish BL.
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [Abstract] [Full Text] [Related]

  • 2. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF, Porter EA, Fischer JJ, Rockwell S.
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [Abstract] [Full Text] [Related]

  • 3. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S, Mate TP, Irvin CG, Nierenburg M.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA, Holden SA, Northey D, Dewhirst MW, Herman TS.
    Int J Radiat Oncol Biol Phys; 1993 Apr 30; 26(1):103-9. PubMed ID: 8482616
    [Abstract] [Full Text] [Related]

  • 5. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA, Herman TS, Rose CM.
    Int J Radiat Oncol Biol Phys; 1988 Nov 30; 15(5):1187-92. PubMed ID: 3141321
    [Abstract] [Full Text] [Related]

  • 6. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA, Rose CM.
    Int J Radiat Oncol Biol Phys; 1986 Aug 30; 12(8):1311-3. PubMed ID: 3093415
    [Abstract] [Full Text] [Related]

  • 7. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S, Irvin CG, Kelley M.
    Int J Radiat Oncol Biol Phys; 1988 Oct 30; 15(4):913-20. PubMed ID: 3141320
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I, Levitt SH, Song CW.
    Radiat Res; 1990 Jun 30; 122(3):275-9. PubMed ID: 2113298
    [Abstract] [Full Text] [Related]

  • 9. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
    Thomas C, Lartigau E, Malaise EP, Guichard M.
    Int J Radiat Oncol Biol Phys; 1989 May 30; 16(5):1157-60. PubMed ID: 2497094
    [Abstract] [Full Text] [Related]

  • 10. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
    Hishikawa-Itoh Y, Kato T, Niwa T, Ayakawa Y, Miyata N.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun 20; 24(6):1243-8. PubMed ID: 2794648
    [Abstract] [Full Text] [Related]

  • 11. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
    Hishikawa-itoh Y, Miyata N.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):781-7. PubMed ID: 2142500
    [Abstract] [Full Text] [Related]

  • 12. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I, Levitt SH, Song CW.
    Radiat Res; 1987 Oct 20; 112(1):173-82. PubMed ID: 3116597
    [Abstract] [Full Text] [Related]

  • 13. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD, Porter E, Yabuki H, Nath R, Rockwell S.
    Radiat Res; 1990 Nov 20; 124(2):178-82. PubMed ID: 2123353
    [Abstract] [Full Text] [Related]

  • 14. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.
    Cancer J Sci Am; 1995 Nov 20; 1(1):43-8. PubMed ID: 9166453
    [Abstract] [Full Text] [Related]

  • 15. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE, Song CW.
    Cancer Chemother Pharmacol; 1989 Nov 20; 25(2):99-102. PubMed ID: 2513138
    [Abstract] [Full Text] [Related]

  • 16. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA, Holden SA, Jacobs JL.
    Cancer Res; 1987 Jan 15; 47(2):513-8. PubMed ID: 3098413
    [Abstract] [Full Text] [Related]

  • 17. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA, Herman TS, Holden SA, Jones SM.
    J Natl Cancer Inst; 1989 Jun 21; 81(12):929-34. PubMed ID: 2525198
    [Abstract] [Full Text] [Related]

  • 18. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D.
    J Cancer Res Clin Oncol; 1992 Jun 21; 118(7):509-14. PubMed ID: 1624542
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF, Kimler BF, Evans RG, Morantz RA, Vats TS.
    NCI Monogr; 1988 Jun 21; (6):119-22. PubMed ID: 3127732
    [Abstract] [Full Text] [Related]

  • 20. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW, Lee I, Hasegawa T, Rhee JG, Levitt SH.
    Cancer Res; 1987 Jan 15; 47(2):442-6. PubMed ID: 3098409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.